Corteva, Inc.
Corteva provides seed and crop protection products to farmers and the agricultural industry in approximately 110 countries. Headquartered in Indianapolis, Indiana, it operates through Seed and Crop Protection segments. The Seed segment develops and supplies commercial seed and trait technologies, including Pioneer and Brevant seeds and Enlist traits. Corteva sells seed directly to farmers through independent representatives, as well as through regional brands, retail outlets and distributors. It also licenses traits and germplasm to third parties. The Crop Protection segment supplies herbicides, insecticides, disease management products, nitrogen stabilizers, seed treatments and biologicals. Its brands include the Enlist weed control system, Zorvec and Utrisha N. Corteva also offers digital solutions that provide farmers with data-driven insights.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CTVA in the last 30 days.
See all $CTVA insider activity →Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an
Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.
Corteva, Inc. reported Q3 Non-GAAP EPS of $0.06, missing estimates by $0.04, with revenue of $1.59B, down 8.6% year-over-year and $180M below expectations. The company attributed the shortfall to lower-than-anticipated demand in certain markets.
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning CTVA (Corteva, Inc.). Coverage has skewed bearish: 0 bullish, 2 neutral, and 7 bearish.
Recent CTVA coverage spans earnings, regulation and financial news.
Corteva issued updated guidance after a decline in net sales and earnings.
The downgrade and lower guidance suggest downside pressure on the stock.
Earnings miss likely pressures the stock lower.
Earnings preview suggests potential upside if results beat expectations, but current sentiment is cautious due to flat revenue guidance.
Vylor (VYLR), spun off from Corteva (CTVA), will report its first earnings on 11 November. The company focuses on seeds and genetics, with targets of 3-4% sales growth and 7-8% EBITDA growth by 2029. Analysts expect Q3 2026 revenue of $846m and a loss per share of $0.44. Vylor has a $3bn share buyback program and a BBB+ credit rating from S&P Global.
AlphAI scores every news story that mentions CTVA with an AI model for sentiment and relevance, and aggregates insider trades from Corteva, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an
Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.
Corteva, Inc. reported Q3 Non-GAAP EPS of $0.06, missing estimates by $0.04, with revenue of $1.59B, down 8.6% year-over-year and $180M below expectations. The company attributed the shortfall to lower-than-anticipated demand in certain markets.
Corteva Inc. reports Q3 earnings Wednesday, its first as a standalone crop protection company. Analysts expect $0.01 EPS on $2.6B revenue, with 12 of 14 analysts rating it a buy and a $17.05 price target. The stock has fallen since its spinoff, trading near a 52-week low. Investors will focus on pipeline innovation, pricing dynamics, and financial guidance.
Vylor (VYLR), spun off from Corteva (CTVA), will report its first earnings on 11 November. The company focuses on seeds and genetics, with targets of 3-4% sales growth and 7-8% EBITDA growth by 2029. Analysts expect Q3 2026 revenue of $846m and a loss per share of $0.44. Vylor has a $3bn share buyback program and a BBB+ credit rating from S&P Global.
Corteva (CTVA) and Franco-Nevada (FNV) report Q3 earnings on November 11. Corteva, now focused on crop protection, faces challenges in volume growth and pricing. Franco-Nevada, up 23.7% YTD despite weak gold, reports amid analyst cuts. Key metrics include crop protection volume for CTVA and revenue for FNV.
Corteva and Inari settled a patent dispute over biological material, ending a trial. Corteva accused Inari of misusing its proprietary seeds, while Inari argued public availability of the seeds allowed their use. The court denied Inari's motion to dismiss, and the DOJ intervened, cautioning against overbroad IP enforcement. The case highlights uncertainties in patent law regarding biological material use.
A federal judge granted preliminary approval for a settlement in a class-action lawsuit against Corteva Inc. and other companies, involving farmers who purchased specific crop products between 2018 and 2026. The lawsuit alleges financial losses due to loyalty programs blocking cheaper generic products. The settlement details, including the dollar amount and allocation, are yet to be released. Corteva previously settled a separate FTC case for $35 million.
The global agrochemical market is projected to reach US$ 387.7 billion by 2031, driven by crop protection needs, regulatory changes, and precision agriculture technologies. Key factors include pest pressure, resistance management, and new product innovations. Companies like Syngenta, BASF, Bayer, and Corteva are involved in strategic developments, such as partnerships and new herbicide registrations.
Corteva Inc. (CTVA) shares fell 3.69% amid concerns over agricultural demand and pricing. The company reported $6.38B in quarterly revenue and $1.16B in net income. The stock collapsed over 80% after spinning off its seed business into Vylor and cutting its dividend from $0.18 to $0.05 per share. The stock now trades around $12, with traders watching for signs of stabilization.
